VMA (Vanillylmandelic Acid), 24-Hour Urine with Creatinine
Test Summary
Urinary vanillylmandelic acid (VMA) concentration is useful in the biochemical diagnosis and monitoring of neuroblastomas [1].
Neuroblastomas occur predominantly in children and are the most common malignancy in those under 1 year old. Neuroblastomas are catecholamine-metabolizing tumors with limited ability to store and secrete catecholamines. Thus, catecholamine metabolites-including VMA and homovanillic acid (HVA)-are more reliable than catecholamines as biochemical markers for neuroblastomas [1]. VMA and HVA levels, usually measured simultaneously, can be elevated in neuroblastomas as well as other catecholamine-secreting tumors, such as pheochromocytoma [1]. In patients with familial dysautonomia (Riley-Day syndrome), a neurological disorder found mainly in individuals of Ashkenazi Jewish descent, VMA levels are generally elevated while HAV levels may be normal or decreased [2].
Urinary VMA and HVA levels may have limited accuracy for diagnosis of neuroblastomas with high-risk metastatic biology [1]. Therefore, dopamine levels in urine or serum have been proposed as an additional marker for diagnosis and monitoring of neuroblastomas [3].
The results of this test should be interpreted in the context of pertinent clinical and family history and physical examination findings.
References
1. Eisenhofer G. Monoamine-producing tumors. In: Rifai R, et al. eds. Tietz Textbook of Laboratory Medicine. 7th ed. Elsevier Inc; 2022.
2. Axelrod FB. Familial dysautonomia. Muscle Nerve. 2004;29(3):352-363.
3. Brodeur GM, et al. J Clin Oncol. 1993;11(8):1466-1477.
Aliases
- N/A
Specimen Collection
Special Instructions
Preferred Specimen
Minimum Volume
Instructions
Record 24-hour urine volume and patient's age on test request form and on urine container.
Patient Preparation
Storage
Transport Temperature
Unpreserved urine: Frozen
Specimen Stability
- Preserved urine
- Room temperature: 10 days
- Refrigerated: 14 days
- Frozen: 1 year
- Unpreserved urine
- Room temperature: Unacceptable
- Refrigerated: Unacceptable
- Frozen: 30 days
Limitations
Other Acceptable Specimens
Unacceptable Specimens
Order Code
EPIC (Premier) Code
Includes
CPT Code
- 82570
- 84585
Billing Code
- 670758
- 670759
- 500002
CPT Statement
Methodology
FDA Status
Physician Attestation of Informed Consent
Testing Laboratory
33608 Ortega Highway
San Juan Capistrano CA, 92675
Department
Reference Range
<3 Years | Not established | |||
3-8 Years | ≤2.3 mg/24 hours | |||
9-12 Years | ≤3.4 mg/24 hours | |||
13-17 Years | ≤3.9 mg/24 hours | |||
Adults | ≤6.0 mg/24 hours |
Creatinine, 24-Hour Urine
<3 Years | Not established | |||
3-8 Years | 0.10-0.80 g/24 h | |||
9-12 Years | 0.20-1.40 g/24 h | |||
13-17 Years | 0.40-1.90 g/24 h | |||
>17 Years | 0.50-2.15 g/24 h |
Setup Schedule / Expected Turnaround Time
Specimen Collection
Special Instructions
Preferred Specimen
Minimum Volume
Instructions
Record 24-hour urine volume and patient's age on test request form and on urine container.
Patient Preparation
Storage
Transport Temperature
Unpreserved urine: Frozen
Specimen Stability
- Preserved urine
- Room temperature: 10 days
- Refrigerated: 14 days
- Frozen: 1 year
- Unpreserved urine
- Room temperature: Unacceptable
- Refrigerated: Unacceptable
- Frozen: 30 days
Limitations
Other Acceptable Specimens
Unacceptable Specimens
Result Information
Methodology
Testing Laboratory
Reference Range
<3 Years | Not established | |||
3-8 Years | ≤2.3 mg/24 hours | |||
9-12 Years | ≤3.4 mg/24 hours | |||
13-17 Years | ≤3.9 mg/24 hours | |||
Adults | ≤6.0 mg/24 hours |
Creatinine, 24-Hour Urine
<3 Years | Not established | |||
3-8 Years | 0.10-0.80 g/24 h | |||
9-12 Years | 0.20-1.40 g/24 h | |||
13-17 Years | 0.40-1.90 g/24 h | |||
>17 Years | 0.50-2.15 g/24 h |